AstraZeneca’s oncology pipeline has suffered a further blow after prostate cancer drug zibotentan failed to meet its primary endpoint of …
US regulators have approved Sanofi-Aventis’ chemotherapy agent Jevtana in combination with the steroid prednisone to treat men with prostate cancer. …

NHS Direct is piloting online decision aids to help patients suffering from osteoporosis or prostate cancer make informed healthcare choices. …